Senior Center Vaccination Clinic

covidvaccine2_336537767

Vaccine Appointments 

Pfizer vaccine appointments are being scheduled for the following dates:

  • Monday, April 19

  • Wednesday, April 21

(The clinic on 4/18 is completely full.)

Pre-registration is now open for ages 16 and up, but seniors will continue to be prioritized in scheduling appointments. If you have already pre-registered with the City of Bowie for an appointment, there is no need to complete another form.  

After 4/19, clinic hours will be 9 a.m. to 1 p.m.

To ensure that seniors are prioritized, City staff is handling the screening and scheduling. There are approximately 800 appointment slots over the three days. City staff members will work their way through the pre-registration list to schedule appointments. You will receive a telephone call when it is your turn to be scheduled. (Please note that the call could come from a number you don’t recognize, so be sure to answer calls on the number that you provide.) 

After your appointment is scheduled, you will receive an email confirmation from Albertsons Patient Care (the parent company of Safeway). The email will provide your appointment details and will contain a link for scheduling your second appointment.

Vaccine Pre-registration Link Opens in new windowPre-register for the clinic

If you have questions about the process, please email publicinfo@cityofbowie.org or call 301-262-6200 (between the hours of 8:30 a.m. and 5 p.m.). 

This clinic is a partnership between the City of Bowie, the State of Maryland, and Safeway Pharmacy.

Information about the Johnson & Johnson Vaccine Pause

Due to the CDC/FDA recommendation to pause administration of the Johnson & Johnson vaccine, all appointments scheduled for the week of April 18 will now be Pfizer. If you originally had a Johnson & Johnson vaccine appointment at the Senior Center, you will need to contact the city to have it rescheduled as a Pfizer appointment. Please call 301-262-6200 for assistance.

Details

On April 13, the CDC and FDA issued a joint statement recommending a pause in administering the Johnson & Johnson. Officials took this step after reports that six individuals in the US had experienced severe reactions to the shot. The reactions have occurred in women age 18-49 and involve an unusual type of blood clot and also affected their blood platelet counts.

The pause will allow the CDC and FDA scientists and the CDC’s independent Advisory Committee on Immunization Practices (ACIP) to review the findings and assess their significance. It will also provide healthcare providers time to become informed about how to recognize the severe symptoms and how to treat them. There is the possibility that educating healthcare providers about these symptoms may result in more reactions being identified.

More than 6.8 million doses of the Johnson & Johnson vaccine have been administered since Emergency Use Authorization was granted on February 28, 2021. In the six individuals, the reactions occurred between 6 and 21 days after vaccination. Warning signs that may indicate the severe reaction to the Johnson & Johnson shot include severe headache, leg or abdomen pain, or shortness of breath.